Stockreport

DarioHealth Reports Fourth Quarter and Full-Year 2023 Financial and Operating Results

DarioHealth Corp.  (DRIO) 
NASDAQ:AMEX Investor Relations: dariohealth.com/our-story
PDF Full-year 2023 revenue of $20.4 million reflects a decrease from 2022 revenue of $7.3 due to a managed decrease in B2C and strategic milestone revenue as the core B2B2C [Read more]